A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
Zhihao Wang,1 Kidane Siele Embaye,1 Qing Yang,2 Lingzhi Qin,1 Chao Zhang,1 Liwei Liu,1 Xiaoqian Zhan,1 Fengdi Zhang,3 Xi Wang,1 Shenghui Qin1 1Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of...
Main Authors: | Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/a-novel-metabolism-related-signature-as-a-candidate-prognostic-biomark-peer-reviewed-article-JHC |
Similar Items
-
Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
by: Junyu Huo, et al.
Published: (2021-06-01) -
Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
by: Junyu Huo, et al.
Published: (2023-01-01) -
Development of a prognostic gene signature for hepatocellular carcinoma
by: Cuiyun Wu, et al.
Published: (2022-01-01) -
A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
by: Xinmin Jin, et al.
Published: (2022-07-01) -
Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients
by: Feng Fang, et al.
Published: (2018-12-01)